Bacterial Infections clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • VABOMERE in Pediatric Subjects With Bacterial Infections

    open to eligible people ages up to 17 years

    A single dose infusion of Vabomere (meropenem-vaborbactam) is being tested for dose-finding, pharmacokinetics, safety, and tolerability in pediatric subjects from birth to less than 18 years of age with serious bacterial infections

    Los Angeles, California and other locations

Our lead scientists for Bacterial Infections research studies include .

Last updated: